The patients in Group 1 had lower incidences of diabetes mellitus (DM), use of renin–angiotensin system blockers, statin, aspirin, clopidogrel, or ticlopidine, and MI or CHF than those in the other three groups. This evidence concerns the gene REN and congestive heart failure.